DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
8	ハンチントン病	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00990613 (ClinicalTrials.gov)	October 2009	6/10/2009	A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin	A Phase 1, Fixed Sequence, Cross-Over Study To Investigate The Single Dose Pharmacokinetics Of A Dimebon (Latrepirdine) Transdermal Solution Relative To The Immediate Release Formulation In Older Adults	Alzheimer's Disease;Huntington's Disease	Drug: Dimebon IR;Drug: Dimebon Transdermal	Pfizer	Medivation, Inc.	Completed	50 Years	85 Years	Both	19	Phase 1	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00990613
(ClinicalTrials.gov)

October 2009

6/10/2009

A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin

A Phase 1, Fixed Sequence, Cross-Over Study To Investigate The Single Dose Pharmacokinetics Of A Dimebon (Latrepirdine) Transdermal Solution Relative To The Immediate Release Formulation In Older Adults

Alzheimer's Disease;Huntington's Disease

Drug: Dimebon IR;Drug: Dimebon Transdermal

Pfizer

Medivation, Inc.

Completed

50 Years

85 Years

Both

Phase 1

United States